A major feature of human immunodeficiency virus (HIV) infection is disordered B-cell function, which paradoxically includes both pathologic overactivity (elevated serum antibodies, lymphadenopathy, and increased risk for lymphoma) and underactivity (impaired antibody immunity, particularly to bacterial polysaccharide antigens). B-cell immune dysfunction contributes significantly to HIV-related morbidity and also represents an obstacle to eventual definitive treatment by anti-HIV immunization. Our laboratory has recently identified in normal B-cell populations certain VH gene subfamilies with a developmentally regulated pattern of utilization. In particular, B cells bearing rearranged VHBL were rare in the germinal center but uniformly abundant in the blood and N NORMAL individuals a critical step in memory B-cell
I differentiation occurs in the germinal center, a specialized lymphoid microenvironment transiently inhabited by activated B cells. Cells successfully completing this developmental stage become part of a recirculating pool of mature memory cells that form the predominant B-cell population in blood and the lymph node mantle zone. The orderly transition from germinal center stage to the quiescent recirculating pool is a key event in B-cell differentiation.
One striking manifestation of human immunodeficiency virus (HIV) infection is the substantial disturbance in differentiation and function of B lymphocytes. On one hand, this involves hypergammaglobulinemia, generalized lymphadenopathy due to B cell hyperplasia, and frequent development of high-grade B-cell lymphomas including Burkitt's lymphoma.'.' On the other hand, it paradoxically involves a markedly impaired ability to generate a primary response to neoantigens: and a poor response to polysaccharides in vivo','o and pokeweed mitogen in vitro.' A peculiar "bare follicle" lymph node histology" and a decline in B cells expressing certain differentiation antigens (Leu-8 and CD21)" are also frequent findings in HIV infection. Many of these B-cell abnormalities occur early in the infection, before substantial depletion of CD4' T cells or clinically evident disease. Moreover, they are manifested even when purified B cells from HIV-positive individuals are tested with normal T cells, suggesting that the functional deficits are intrinsic to the B cell.I3
Previously, we have observed that B cells bearing certain rearranged VH3 genes (VH3L) were developmentally restricted. That is, VH3L B cells were uniquely deficient in germinal center cells but abundant in blood and the lymph node mantle zone B-cell population. This restriction appears to be due to a selective expansion of VH3L B cells in the postgerminal center B-cell pop~lation.'~ Using a polymerase chain reaction (PCR) based strategy, we have now tested VH3L as an index gene to evaluate this transitional event of B-cell development in HIV-positive individuals. ing strand sequence, FR1, codons 6 through 12, VH3); VH4/6, 5'dCCAGGACTGGTGAAGCC (coding strand sequence, FR1, codons 9 through 14, VH4 and VH6); VHSN, 5'dCCTCCA-CAGGGTGAGTATCC (coding strand sequence, 5' flank, -68 to -50 upstream of translational start site, VH5); JHKOR, 5'dAGT-GCCAACCGCCTCACAGG (noncoding strand sequence, codons 108 to 2 nt 3' of codon 113A, consensus human JH); ras83, 5'dGGGATTCTTACCGAAAGCAAGTG (coding strand sequence of exon I1 of the human N-rus proto-oncogene; ras84, 5'dATAATAAACTACCGTTTATGTG (noncoding strand sequence within exon I1 of the human N-ras proto-oncogene.
MATERIALS AND METHODS

Subjects and specimen preparation. Peripheral blood samples
Quantitation of genomic
Amplification reactions were performed based on standard conditions using 200 ng of predenatured (94"C, 2 minutes) geaomic DNA templates, 0.5 U Themus aquaticus DNA polymerase (Taq) (Perkin-Elmer/Cetus, Emeryville, CA), 100 pmol oligonucleotide (each), 200 pmol dNTP, and 0.1 pCi ''P-[a]-dCTP (Amersham, Chicago, IL) with a final reaction volume of 100 pL. Reaction mixtures for VH3L were subjected to 40 successive cycles consisting of heat denaturation (94"C, 1 minute), annealing, and primer extension (72"C, 2 minutes). Reaction mixtures for N-rus and the remaining VH subfamilies were subjected to 40 successive cycles consisting of: heat denaturation (94"C, 1 minute), annealing (55"C, 1 minute), and primer extension (72"C, 2 minutes) using the Bellco DNA Pacer (Vineland, NJ). PCR products were fractionated using 1%/1% Nu-SieveLE agarose (FMC, Rockland, ME) in l x TPE (0.08 mol/L TRIS-phosphate, 0.008 molL EDTA) buffer. Gels were briefly stained with ethidium bromide to visualize bands; the apparent sizes of the amplified products were: VHlN, 440 bp; VH3L, 380 bp; VH4/6, 434 bp; VHSN, 583 bp and N-ras, 147 bp. N-rus, a single copy gene, was included as a control for the quality of DNA harvested and a normalizing denominator for PCR reactions. For quantitative data, bands from agarose gels were excised and Cerenkov counts measured using Beckman LS-7000 scintillation counter (Palo Alto, CA).
RESULTS
The abundance of B cells bearing rearranged VH subfamilies was determined using VH-specific oligonucleotides in a quantitative PCR assay (see Materials and Methods). An initial examination of blood samples from five HIV-positive and three normal individuals is shown in Fig 1. B cells bearing rearranged VH subfamilies (VHlN, VH4/6, VH5N) were abundant in both populations. VH3L B cells were also abundant in the normal individuals, but unexpectedly were deficient in this initial study of HIV-positive individuals. To confirm whether these distinct levels of VH3L B cells were characteristic of each population, an expanded panel of additional subjects was tested (Fig 2) . This panel included 13 HIV-positive subjects and 10 normal subjects. Two samples from HIV-positive individuals (lanes 5 and 13) were excluded because of insufficient DNA. Again, a uniform deficit of VH3L B cells was observed exclusively in HIV-positive subjects. It is interesting to note an apparent overabundance of VH1 and VH4/6 in the HIV-positive patients in Fig 1. If so, this could suggest a compensatory mechanism or an additional aspect of the clonal selection process affecting HIV B-cell populations that might merit further study.
We questioned whether this was a distinctive pattern in the blood compartment or reflected a systemic lymphoid deficit. To address this issue, we selected archival tissues of spleen and lymph node from three HIV-positive and three HIV-negative autopsies (Fig 3) . These six autopsy cases were performed during 1989 through 1990, all were males and matched for age (20 to 35 years). All three HIVpositive cases had documented physical findings of lymphadenopathy. The histologic findings in this group included (Fig 4) . Gcncrally, VH3L R cclls wcrc fivc timcs morc ahundiint in normal splccn and thrcc to four timcs morc abundant in normal lymph nodc comparcd with corrcsponding HIV-positivc tirsucs. This cxamination of pcriphcrid hlcKK1 lymphocytcs (PRLs) and autopsy tissucs idcntilics a VH clonal B-ccll dcficit in HIV-positivc individuals.
DISCUSS ION
This study dcscrihes a profound dcficit of VH3L B cclls in HIV-positivc individuals. In contrast to this sclcctivc dcficit. othcr VH gcnc suhfamilics rcmaincd rclativcly unaffcctcd. This dcplction was not only localizcd to blood. hut also prcscnt in splccn and lymph nodc populations. A simplc cxplanation for this cloniil dcficit would hc that VH3L rcprcscnts a €3-ccll suhsct that is a natural targct for HIV infcction, analogous to thc CD4' Tccll suhsct. H wcvcr. most cvidcncc indicates that R cclls arc not susccptihlc to dircct HIV infcction." A morc promising explanation is that thc Bccll dcficit is a rcsult of an immunophysiologic disturhdncc intcrfcring with propcr Bccll maturation with aswiatcd impairmcnt in Rccll function. Wc hccamc We have recently reported that common variable immunodeficiency (CVI), a rare disorder of quantitative and qualitative antibody production, is also characterized in most cases by a germinal center maturational arrest of B cells, including the same functional, phenotypic, and clonal (eg, VH3L) abnormalities noted in HIV infection.".25," Curiously, CVI and HIV infection also share the feature of systemically elevated interleukin-6 with its immunopathologic and clinical ~e q u e l a e .~~,~ Taken together, these findings strongly support the idea that HIV-associated defect in B-cell development defines a class of immunodeficiency diseases that involves a maturational arrest at the germinal center stage.
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